Kashiv BioSciences Announces Positive Topline Results from Confirmatory Efficacy Study of ADL-018, Biosimilar Candidate to XOLAIR® (omalizumab)
Positive results from the confirmatory clinical efficacy and safety study of ADL-018, proposed biosimilar to … Business Wire India Positive…